CVE-2024-51902 identifies a stored Cross-site Scripting (XSS) vulnerability in cybio TinyCode, a software product used primarily in laboratory automation and biotech environments. The vulnerability stems from improper neutralization of user-supplied input during web page generation, allowing malicious scripts to be stored and later executed in the context of users’ browsers. This stored XSS flaw means that any user accessing the compromised page could have arbitrary JavaScript executed, potentially leading to session hijacking, unauthorized actions, or malware delivery. The affected versions include all releases up to and including version 1.2.1. No CVSS score has been assigned yet, and no public exploits have been reported. However, the vulnerability is critical because stored XSS can be exploited remotely without authentication and can affect multiple users. The root cause is insufficient input sanitization and output encoding in the TinyCode web interface. Given the product’s use in sensitive laboratory and biotech settings, exploitation could compromise data confidentiality and integrity, disrupt operations, or facilitate further attacks within organizational networks.

The impact of CVE-2024-51902 is significant for organizations using cybio TinyCode, especially in biotech, pharmaceutical, and research laboratories where the software is deployed for automation and data management. Successful exploitation can lead to unauthorized access to user sessions, theft of sensitive data, and injection of malicious payloads that compromise system integrity. This could result in data breaches, manipulation of experimental results, or disruption of critical laboratory workflows. Additionally, attackers could leverage the vulnerability to pivot into internal networks, escalating the scope of the attack. The lack of authentication requirements for exploitation increases the risk of widespread attacks. Although no known exploits are currently in the wild, the vulnerability’s nature makes it a prime target for attackers once publicized. Organizations failing to address this issue may face reputational damage, regulatory penalties, and operational downtime.

To mitigate CVE-2024-51902, organizations should prioritize the following actions: 1) Monitor cybio’s official channels for patches addressing this vulnerability and apply them promptly once released. 2) Until patches are available, implement strict input validation on all user inputs to ensure that scripts or HTML tags are not accepted. 3) Employ robust output encoding techniques on all data rendered in web pages to neutralize potentially malicious content. 4) Use Content Security Policy (CSP) headers to restrict the execution of unauthorized scripts in browsers. 5) Conduct regular security audits and penetration testing focusing on web application input handling. 6) Educate users about the risks of clicking suspicious links or interacting with untrusted content within the application. 7) Consider network segmentation to limit access to the TinyCode interface to trusted users and systems only. These steps will reduce the risk of exploitation and limit potential damage.